Table 3.
COVID-19-related anamnesis of Slovak healthcare workers who received BNT162b2, February–March 2021 (n = 522).
| Variable | Outcome | Female (n = 402) | Male (n = 120) | Total (n = 522) | Sig. |
|---|---|---|---|---|---|
| Prior Infection | Yes | 53 (13.2%) | 16 (13.3%) | 69 (13.2%) | 0.966 |
| No | 349 (86.8%) | 104 (86.7%) | 453 (86.8%) | ||
| Prior Contact | Yes | 232 (57.7%) | 86 (71.7%) | 318 (60.9%) | 0.006 |
| No | 170 (42.3%) | 34 (28.3%) | 204 (39.1%) | ||
| Duration | 2nd Dose–1st Dose | 28.14 ± 4.95 | 29.55 ± 10.11 | 28.46 ± 6.52 | 0.027 |
Chi-squared test (χ2) and Mann–Whitney test (U) were used with a significance level (Sig.) of < 0.05.